Meeting
2022 ASCO Annual Meeting
Determining concordance of LFSPRO TP53 germline carrier risk predictions to standard genetic counseling practice.
Authors
Elissa B. Dodd-Eaton
The University of Texas MD Anderson Cancer Center, Houston, TX
Elissa B. Dodd-Eaton , Hoai Nam Nguyen , Jessica Corredor , Jacynda Woodman-Ross , Gang Peng , Sierra Green , Nathaniel D. Hernandez , Angelica Gutierrez Barrera , Banu Arun , Wenyi Wang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 10593)
DOI
10.1200/JCO.2022.40.16_suppl.10593
Abstract #
10593
Poster Bd #
468
Abstract Disclosures
Similar Posters
Poster
2011 ASCO Annual Meeting
Identification of previously unrecognized germline p53 mutations in Li-Fraumeni syndrome patients through retesting of archival DNA samples.
First Author: A. Novokmet
Poster
2018 ASCO Annual Meeting
Mosaic TP53 pathogenic variants on multi-gene hereditary cancer panel testing: Clinical characteristics and follow-up testing.
First Author: Sarah A. Jackson
Poster
2022 ASCO Annual Meeting
Pathogenic TP53 variant allele frequency across different somatic tissues in two patients with mosaic Li-Fraumeni.
First Author: Tin-Yun Tang
Poster
2022 ASCO Annual Meeting
Fertility preferences, concerns, and preservation among young women with breast cancer who carry germline genetic pathogenic variants compared with non-carriers.
First Author: Rebecca M. Lewinsohn